BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robida PA, Rische CH, Morgenstern NB, Janarthanam R, Cao Y, Krier-Burris RA, Korver W, Xu A, Luu T, Schanin J, Leung J, Rothenberg ME, Wechsler JB, Youngblood BA, Bochner BS, O'Sullivan JA. Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells. Cells 2022;11:1138. [PMID: 35406705 DOI: 10.3390/cells11071138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Smiljkovic D, Herrmann H, Sadovnik I, Gamperl S, Berger D, Stefanzl G, Eisenwort G, Hoermann G, Kopanja S, Dorofeeva Y, Focke-Tejkl M, Jaksch P, Hoetzenecker K, Szepfalusi Z, Valenta R, Arock M, Valent P. Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils. J Allergy Clin Immunol 2023;151:202-11. [PMID: 35953001 DOI: 10.1016/j.jaci.2022.07.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Poto R, Criscuolo G, Marone G, Brightling CE, Varricchi G. Human Lung Mast Cells: Therapeutic Implications in Asthma. Int J Mol Sci 2022;23. [PMID: 36430941 DOI: 10.3390/ijms232214466] [Reference Citation Analysis]
3 Schanin J, Korver W, Brock EC, Leung J, Benet Z, Luu T, Chang K, Xu A, De Freitas N, Luehrsen K, Brehm MA, Wong A, Youngblood BA. Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells. Commun Biol 2022;5:1226. [DOI: 10.1038/s42003-022-04207-w] [Reference Citation Analysis]
4 Bochner BS, O'Sullivan JA, Chang AT, Youngblood BA. Siglecs in allergy and asthma. Mol Aspects Med 2022;90:101104. [PMID: 35835621 DOI: 10.1016/j.mam.2022.101104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]